Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8


Invariant Natural Killer T Cells in Immune Regulation of Blood Cancers: Harnessing Their Potential in Immunotherapies.

Lam PY, Nissen MD, Mattarollo SR.

Front Immunol. 2017 Oct 23;8:1355. doi: 10.3389/fimmu.2017.01355. eCollection 2017. Review.


Bone Marrow Immunity and Myelodysplasia.

Lambert C, Wu Y, Aanei C.

Front Oncol. 2016 Jul 20;6:172. doi: 10.3389/fonc.2016.00172. eCollection 2016. Review.


GATA2 deficiency-associated bone marrow disorder differs from idiopathic aplastic anemia.

Ganapathi KA, Townsley DM, Hsu AP, Arthur DC, Zerbe CS, Cuellar-Rodriguez J, Hickstein DD, Rosenzweig SD, Braylan RC, Young NS, Holland SM, Calvo KR.

Blood. 2015 Jan 1;125(1):56-70. doi: 10.1182/blood-2014-06-580340. Epub 2014 Oct 30.


OCH ameliorates bone marrow failure in mice via downregulation of T-bet expression.

Qiao X, Xie X, Shi W, Tang J, Shao Y, Li F.

J Immunol Res. 2014;2014:928743. doi: 10.1155/2014/928743. Epub 2014 Aug 28.


Immunosenescence and Challenges of Vaccination against Influenza in the Aging Population.

Reber AJ, Chirkova T, Kim JH, Cao W, Biber R, Shay DK, Sambhara S.

Aging Dis. 2012 Feb;3(1):68-90. Epub 2011 Sep 30.


Harnessing human CD1d restricted T cells for tumor immunity: progress and challenges.

Dhodapkar MV.

Front Biosci (Landmark Ed). 2009 Jan 1;14:796-807. Review.


Enhancement of ligand-dependent activation of human natural killer T cells by lenalidomide: therapeutic implications.

Chang DH, Liu N, Klimek V, Hassoun H, Mazumder A, Nimer SD, Jagannath S, Dhodapkar MV.

Blood. 2006 Jul 15;108(2):618-21. Epub 2006 Mar 28.


Preferential suppression of trisomy 8 compared with normal hematopoietic cell growth by autologous lymphocytes in patients with trisomy 8 myelodysplastic syndrome.

Sloand EM, Mainwaring L, Fuhrer M, Ramkissoon S, Risitano AM, Keyvanafar K, Lu J, Basu A, Barrett AJ, Young NS.

Blood. 2005 Aug 1;106(3):841-51. Epub 2005 Apr 12.

Supplemental Content

Support Center